BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 25858462)

  • 1. An exercise regimen prevents development paclitaxel induced peripheral neuropathy in a mouse model.
    Park JS; Kim S; Hoke A
    J Peripher Nerv Syst; 2015 Mar; 20(1):7-14. PubMed ID: 25858462
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lithium attenuates peripheral neuropathy induced by paclitaxel in rats.
    Pourmohammadi N; Alimoradi H; Mehr SE; Hassanzadeh G; Hadian MR; Sharifzadeh M; Bakhtiarian A; Dehpour AR
    Basic Clin Pharmacol Toxicol; 2012 Mar; 110(3):231-7. PubMed ID: 21917116
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Deletion of Sarm1 gene is neuroprotective in two models of peripheral neuropathy.
    Turkiew E; Falconer D; Reed N; Höke A
    J Peripher Nerv Syst; 2017 Sep; 22(3):162-171. PubMed ID: 28485482
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ganglioside GM1 (porcine) ameliorates paclitaxel-induced neuropathy in rats.
    Chentanez V; Thanomsridejchai N; Duangmardphon N; Agthong S; Kaewsema A; Huanmanop T; Maneesri S
    J Med Assoc Thai; 2009 Jan; 92(1):50-7. PubMed ID: 19260244
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dorsal Root Ganglion Infiltration by Macrophages Contributes to Paclitaxel Chemotherapy-Induced Peripheral Neuropathy.
    Zhang H; Li Y; de Carvalho-Barbosa M; Kavelaars A; Heijnen CJ; Albrecht PJ; Dougherty PM
    J Pain; 2016 Jul; 17(7):775-86. PubMed ID: 26979998
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Peptidergic intraepidermal nerve fibers in the skin contribute to the neuropathic pain in paclitaxel-induced peripheral neuropathy.
    Ko MH; Hu ME; Hsieh YL; Lan CT; Tseng TJ
    Neuropeptides; 2014 Jun; 48(3):109-17. PubMed ID: 24630273
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Beneficial effects of Gelsemium-based treatment against paclitaxel-induced painful symptoms.
    Vitet L; Patte-Mensah C; Boujedaini N; Mensah-Nyagan AG; Meyer L
    Neurol Sci; 2018 Dec; 39(12):2183-2196. PubMed ID: 30251080
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting Axon Integrity to Prevent Chemotherapy-Induced Peripheral Neuropathy.
    Chine VB; Au NPB; Kumar G; Ma CHE
    Mol Neurobiol; 2019 May; 56(5):3244-3259. PubMed ID: 30117103
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevention of chemotherapy-induced peripheral neuropathy by the small-molecule inhibitor pifithrin-μ.
    Krukowski K; Nijboer CH; Huo X; Kavelaars A; Heijnen CJ
    Pain; 2015 Nov; 156(11):2184-2192. PubMed ID: 26473292
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Schedule dependency of paclitaxel-induced neuropathy in mice: a morphological study.
    Mimura Y; Kato H; Eguchi K; Ogawa T
    Neurotoxicology; 2000 Aug; 21(4):513-20. PubMed ID: 11022860
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Herbal medicine Shakuyaku-kanzo-to reduces paclitaxel-induced painful peripheral neuropathy in mice.
    Hidaka T; Shima T; Nagira K; Ieki M; Nakamura T; Aono Y; Kuraishi Y; Arai T; Saito S
    Eur J Pain; 2009 Jan; 13(1):22-7. PubMed ID: 18472288
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacological Modulation of the Mitochondrial Electron Transport Chain in Paclitaxel-Induced Painful Peripheral Neuropathy.
    Griffiths LA; Flatters SJ
    J Pain; 2015 Oct; 16(10):981-94. PubMed ID: 26142652
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neurosteroid 3α-androstanediol efficiently counteracts paclitaxel-induced peripheral neuropathy and painful symptoms.
    Meyer L; Patte-Mensah C; Taleb O; Mensah-Nyagan AG
    PLoS One; 2013; 8(11):e80915. PubMed ID: 24260511
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacological SARM1 inhibition protects axon structure and function in paclitaxel-induced peripheral neuropathy.
    Bosanac T; Hughes RO; Engber T; Devraj R; Brearley A; Danker K; Young K; Kopatz J; Hermann M; Berthemy A; Boyce S; Bentley J; Krauss R
    Brain; 2021 Nov; 144(10):3226-3238. PubMed ID: 33964142
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevention of vincristine-induced peripheral neuropathy by genetic deletion of SARM1 in mice.
    Geisler S; Doan RA; Strickland A; Huang X; Milbrandt J; DiAntonio A
    Brain; 2016 Dec; 139(Pt 12):3092-3108. PubMed ID: 27797810
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evoked and Ongoing Pain-Like Behaviours in a Rat Model of Paclitaxel-Induced Peripheral Neuropathy.
    Griffiths LA; Duggett NA; Pitcher AL; Flatters SJL
    Pain Res Manag; 2018; 2018():8217613. PubMed ID: 29973969
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of fluocinolone acetonide to prevent paclitaxel-induced peripheral neuropathy.
    Cetinkaya-Fisgin A; Joo MG; Ping X; Thakor NV; Ozturk C; Hoke A; Yang IH
    J Peripher Nerv Syst; 2016 Sep; 21(3):128-33. PubMed ID: 27117347
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevention of paclitaxel-induced neuropathy through activation of the central cannabinoid type 2 receptor system.
    Naguib M; Xu JJ; Diaz P; Brown DL; Cogdell D; Bie B; Hu J; Craig S; Hittelman WN
    Anesth Analg; 2012 May; 114(5):1104-20. PubMed ID: 22392969
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interleukin-6 protects against paclitaxel, cisplatin and vincristine-induced neuropathies without impairing chemotherapeutic activity.
    Callizot N; Andriambeloson E; Glass J; Revel M; Ferro P; Cirillo R; Vitte PA; Dreano M
    Cancer Chemother Pharmacol; 2008 Nov; 62(6):995-1007. PubMed ID: 18270703
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Electrophysiological features of the mouse tail nerves and their changes in chemotherapy induced peripheral neuropathy (CIPN).
    Leandri M; Ghignotti M; Emionite L; Leandri S; Cilli M
    J Neurosci Methods; 2012 Aug; 209(2):403-9. PubMed ID: 22800858
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.